SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. revenue for the last year amounted to 2.63 B CNY, the most of which — 1.06 B CNY — came from its highest performing source at the moment, Medical Aesthetics and Wound Care, the year earlier bringing 748.14 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO. LTD. 2.20 B CNY, and the year before that — 1.73 B CNY.